Lieff Cabraser represents young men prescribed the medication Risperdal who developed abnormal breasts. The personal injury lawsuits charge that Risperdal is a defective and dangerous prescription drug and seek monetary damages for the mental anguish and physical injuries the young men suffered.
Risperdal Linked to Boys and Young Men Growing Breasts
Gynecomastia is the growth of abnormal breast tissue in males. These are not merely fatty deposits in the pectoral muscles of the chest, but real breasts that look like women’s breasts. Risperdal and its companion drug Invega have been linked to causing gynecomastia.
Attorney Wendy Fleishman Provides Information on Risperdal and Gynecomastia Side Effects in Young Men
Risperdal Lawsuits and Settlement with Government
In the first Risperdal trial, a jury in February 2015 found J&J liable for failing to warn that Risperdal could cause gynecomastia. The lawsuit was brought by the family of an autistic boy who took the drug in 2002 and later developed size 46 DD breasts, according to a lawyer for the family.
In 2013, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the manufactures of Risperdal and Invega, entered into a $2.2 billion settlement with the U.S. Department of Justice for over promoting the drugs. The settlement money was paid solely to the government.
Lieff Cabraser is seeking monetary compensation for the boys and young men whose bodies have developed women’s breasts. The Risperdal lawsuits charge that J&J and new Risperdal triggered stimulated male breast development and failed to adequately warn physicians, parents, and the adolescents prescribed Risperdal of this side effect.
Legal Rights of Risperdal Users
Manufacturers of prescription drugs have a duty to produce safe products. Drug makers are also required under federal law to fully warn patients — and their parents if the patients are children — and their doctors of any adverse health effects. Adult males prescribed Risperdal either as children or as young adults may file personal injury lawsuits against J&J and Janssen and seek compensation for their injuries, as well as past and future medical expenses for treating gynecomastia.
Risperdal and Invega are trademarks owned by Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, and used for product identification purposes only. Lieff Cabraser is not affiliated with these companies. This website has not been endorsed or approved by Johnson & Johnson and Janssen Pharmaceuticals.